FDA OKs Invitrogen genetic test for breast cancer
Tuesday, July 8, 2008 - 09:35
in Health & Medicine
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Invitrogen Corp's genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin.